Funded Tech Companies
Syntimmune
Wondering who bought Syntimmune? The company was purchased by Alexion Pharmaceuticals.
Company Overview
Company Name
Syntimmune
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
116 Huntington Ave. 301
Boston, MA 02116
USA
Boston, MA 02116
USA
Phone
Website
Email Address
Company Background Information
Overview
Founded in 2013, Syntimmune is the world's leader in the biology of the neonatal Fc receptor (FcRn). Helmed by the most recognized experts in its field, Syntimmune is positioned to rapidly advance breakthrough therapies which co-opt this unique target.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/26/2018
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jean Kress
Chief Financial Officer
John McBride
Chief Medical Officer
Mario Saltarelli
Vice President
Stephanie Haller
Vice President
Nicole Luosey
VP - Operations
Adam Hansard
VP - Regulatory Affairs
Donald Johns
VP - Regulatory Affairs
Leslie Stolz
Company Investors
- Apple Tree Partners (Sam Hall)
- Baxalta Ventures
- Apple Tree Partners (David Graaf)
- Partners Innovation Fund
Browse more funded tech companies:
Syntiant | Syntonix Pharmaceuticals
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs